Funding for neurotechnology poses unique challenges and offers substantial opportunities for medical device investors, compared to other fields like cardiovascular or ophthalmology.
Ken Mariash emphasized, "This is one of the hottest areas in medtech, despite the downturn in funding." Ana Maiques added, "Traditional Life Science investors in Boston tend to do a lot of biotech. Neuro was really hard to raise money. But, in the last few years, phenomenal companies like Syncron and other great companies have been doing great funding rounds."